OncoSec Medical (ONCS) News Today → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free ONCS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 24, 2023 | finance.yahoo.comONCS - OncoSec Medical IncorporatedJune 23, 2023 | markets.businessinsider.comWhy Is OncoSec Medical (ONCS) Stock Up 100% Today?June 15, 2023 | msn.comWhy John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 15, 2023 | msn.comWhy Is OncoSec Medical (ONCS) Stock Down 48% Today?June 14, 2023 | marketbeat.comTrading was temporarily halted for "ONCS" at 04:06 PM with a stated reason of "News pending."May 18, 2023 | finance.yahoo.comOncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 16, 2023 | msn.comOncoSec Medical plunges 35% lower on sale of 1.4M shares of common stockMay 16, 2023 | finance.yahoo.comOncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 16, 2023 | finance.yahoo.comOncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical programApril 27, 2023 | finance.yahoo.comOncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL ProgramApril 11, 2023 | finance.yahoo.comOncoSec Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 10, 2023 | msn.comWhy OncoSec Medical Shares Are Soaring TodayApril 10, 2023 | finance.yahoo.comOncoSec Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 10, 2023 | marketbeat.comTrading was temporarily halted for "ONCS" at 11:04 AM with a stated reason of "LULD pause."April 6, 2023 | benzinga.comOncoSec Medical Inc (ONCS) is lower by 6.15% Tuesday In Premarket TradingApril 3, 2023 | finance.yahoo.comOncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For Neoadjuvant Setting StudyApril 3, 2023 | msn.comOncoSec crashes ~60% after TAVO-EP, Keytruda combo fails phase 2 skin cancer trialApril 3, 2023 | finance.yahoo.comOncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 TreatmentMarch 1, 2023 | marketwatch.comOncoSec Medical Withdraws Planned Offering, Shares Rise Over 50%March 1, 2023 | msn.comWhy is OncoSec Medical (ONCS) Stock Up 91% Today?January 16, 2023 | reuters.comONCS.OQ - | Stock Price & Latest News | ReutersJanuary 5, 2023 | benzinga.comOncoSec Medical Stock (NASDAQ:ONCS), Quotes and News SummaryDecember 8, 2022 | msn.comPeering Into OncoSec Medical's Recent Short InterestDecember 5, 2022 | finance.yahoo.comOncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022November 30, 2022 | marketwatch.comOncoSec Shares Drop 25% on Equity Offer Pricing After 51% Tuesday SurgeNovember 30, 2022 | finance.yahoo.comOncoSec Announces Pricing of $3.5 Million Public OfferingNovember 24, 2022 | finance.yahoo.comOncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin CancerNovember 23, 2022 | seekingalpha.comOncoSec provides updates on cancer programs in new filingNovember 22, 2022 | msn.comLooking Into OncoSec Medical's Recent Short InterestNovember 21, 2022 | marketbeat.comTrading was temporarily halted for "ONCS" at 03:11 PM with a stated reason of "LULD pause."November 21, 2022 | marketbeat.comTrading was temporarily halted for "ONCS" at 12:11 PM with a stated reason of "LULD pause."November 15, 2022 | finance.yahoo.comOncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanomaNovember 11, 2022 | finance.yahoo.comOncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 TreatmentNovember 8, 2022 | marketwatch.comOncoSec Medical Shares Hit New Depths Ahead of Reverse Stock Split >ONCSNovember 8, 2022 | finance.yahoo.comOncoSec Announces Reverse Stock SplitOctober 13, 2022 | finance.yahoo.comOncoSec Cuts Workforce, Prioritizes PipelineOctober 4, 2022 | marketwatch.comOncoSec Medical to Restructure, Cut JobsOctober 4, 2022 | markets.businessinsider.comOncoSec Medical To Reduce Staff By About 45%October 4, 2022 | finance.yahoo.comOncoSec Announces Pipeline Prioritization and Workforce ReductionApril 29, 2022 | seekingalpha.comRobert Arch joins OncoSec Medical as CEOApril 29, 2022 | finance.yahoo.comOncoSec Appoints Dr. Robert Arch as President and Chief Executive OfficerMarch 16, 2022 | benzinga.comBTIG Maintains Buy on OncoSec Medical, Lowers Price Target to $5March 16, 2022 | marketbeat.comOncoSec Medical (NASDAQ:ONCS) PT Lowered to $5.00BTIG Research lowered their price objective on OncoSec Medical from $10.00 to $5.00 in a research report on Wednesday.February 23, 2022 | seekingalpha.comOncoSec appoints new finance chiefOctober 9, 2021 | nasdaq.comOncoSec Medical Inc Shares Approach 52-Week Low - Market MoverAugust 3, 2021 | finance.yahoo.comOncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology ConferenceJuly 27, 2021 | nasdaq.comOncoSec Medical Incorporated Common Stock (ONCS) Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. ONCS Media Mentions By Week ONCS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCS News Sentiment▼0.000.55▲Average Medical News Sentiment ONCS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCS Articles This Week▼01▲ONCS Articles Average Week Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 9 Meters Biopharma News Eiger BioPharmaceuticals News Sintx Technologies News GRI Bio News Acutus Medical News Lucy Scientific Discovery News Nemaura Medical News Virax Biolabs Group News Helius Medical Technologies News NeuBase Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
